A PILOT STUDY OF THE COMBINATION OF SORAFENIB PLUS NIVOLUMAB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC): SAFETY, EFFICACY, AND IMMUNE CELL PROFILING IN CHILD PUGH A AND B COHORTS
HEPATOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined